Ondine Biomedical Inc Market Cap ($614.56K)
Market Cap & Net Worth: Ondine Biomedical Inc (OBI)
Ondine Biomedical Inc market cap. Ondine Biomedical Inc (LSE:OBI) has a market capitalization of $614.56K (GBX5.05 Billion) as of November 7, 2026. Listed on the LSE stock exchange, this UK-based company holds position #30957 globally and #885 in its home market, demonstrating a -7.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ondine Biomedical Inc's stock price GBX9.00 by its total outstanding shares 561218135 (561.22 Million). Also see cash flow conversion of Ondine Biomedical Inc for how efficiently the company converts equity into cash flow.
Ondine Biomedical Inc Market Cap History (2021–2026)
Ondine Biomedical Inc market cap history from 2021 to 2026. Data shows change from $3.79 Million to $614.56K (-31.52% CAGR). Check OBI share price today for real-time trading data and today's change.
Index Memberships
Ondine Biomedical Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$990.01 Million | 0.06% | #199 of 722 |
Weight: Ondine Biomedical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ondine Biomedical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ondine Biomedical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore OBI year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.23x
Ondine Biomedical Inc's market cap is 0.23 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.79 Million | $2.57 Million | -$50.09 Million | 1.48x | N/A |
| 2022 | $1.40 Million | $638.00K | -$19.37 Million | 2.19x | N/A |
| 2023 | $597.49K | $1.20 Million | -$14.41 Million | 0.50x | N/A |
| 2024 | $597.49K | $2.05 Million | -$19.10 Million | 0.29x | N/A |
| 2025 | $597.49K | $2.65 Million | -$29.59 Million | 0.23x | N/A |
Competitor Companies of OBI by Market Capitalization
Companies near Ondine Biomedical Inc in the global market cap rankings as of November 7, 2026. Also see Ondine Biomedical Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Ondine Biomedical Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Ondine Biomedical Inc (2021–2026)
Market capitalization of Ondine Biomedical Inc from 2021 to today. Between 2021 and today, Ondine Biomedical Inc's market cap moved from $3.79 Million to $ 614.56K, with a yearly change of -31.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX614.56K | +2.86% |
| 2025 | GBX597.49K | 0.00% |
| 2024 | GBX597.49K | 0.00% |
| 2023 | GBX597.49K | -57.32% |
| 2022 | GBX1.40 Million | -63.06% |
| 2021 | GBX3.79 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Ondine Biomedical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $614.56K USD |
| MoneyControl | $614.56K USD |
| MarketWatch | $614.56K USD |
| marketcap.company | $614.56K USD |
| Reuters | $614.56K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ondine Biomedical Inc
Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose. In addition, the company offers a pipeline of photodisinfecti… Read more